Department of Public Health and Social Services Guam Public Health Laboratory (GPHL) March 11, 2014.

Slides:



Advertisements
Similar presentations
The Role of Laboratories in Surveillance Mahon 2006 Arnold Bosman Source: WHO-Lyon, Julia Fitzner, 2004.
Advertisements

Nick Curry, MD, MPH Infectious Diseases Prevention Section
DCLS Influenza Laboratory Testing Denise M. Toney, Ph.D. Commonwealth of Virginia Division of Consolidated Laboratory Services H & M Panel – May 2009.
Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
The Laboratory Response Network
The Way Ahead How can we make a difference for good as a result of this meeting? What problems are we trying to solve? Laboratory Capacity? Clinical/Diagnostics,
Implementation of Diagnostics in Resource-Limited Settings Amy Piatek Global Health Bureau, Office of Health, Infectious Diseases & Nutrition U.S. Agency.
1 Regionalizing Public Health Systems: A CyberSeminar Presented by Dave Palm Office of Public Health Nebraska Health and Human Services System May 23,
Capability Cliff Notes Series PHEP Capability 13—Public Health Surveillance and Epidemiological Investigation What Is It And How Will We Measure It?
SPECIMEN HANDLING: from patient bedside to the laboratories (clinical, commercial and public health) Patricia A. Somsel, Dr.P.H. Michigan Department of.
AUL Purpose The AUL is organized for support and cooperative purposes by its members. These purposes are: – To strengthen lab network in the USAPI countries.
VIRAL AND ZOONOTIC DISEASE RESEARCH PROGRM VZDRP Study. Monitor. Detect Empowering nations and agencies through collaboration, with the means to better.
Role of the laboratory in disease surveillance
Epidemiologic Preparedness and Response to Terrorist Events Involving the Nation’s Food Supply Jeremy Sobel, MD MPH Foodborne and Diarrheal Diseases Branch.
The Laboratory Response Network
Region I Advisory Board Meeting Wells Beach, ME June 9, 2008 Use and Verification of STD Nucleic Acid Amplification Tests for non-FDA Cleared Clinical.
THE PIHOA REGIONAL LABORATORY STRENGTHENING INITIATIVE Vasiti Uluiviti Regional Laboratory Coordinator PIHOA 55 th Meeting – PNI, FedSM March 10 th - 13.
SPC Initiative Update Research, Evidence and Information (REI) Programme PHD 57 th PIHOA Executive Meeting, Palau 9 th -12 th March, 2015 Dr Yvan Souares,
Gonococcal Isolate Surveillance Project (GISP)
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
Capability Cliff Notes Series PHEP Capability 12—Public Health Laboratory Testing What Is It And How Will We Measure It?
COMPREHENSIVE APPROACH TO TB DIAGNOSIS
Laboratory Response Network Spokane Regional Health District.
Association of Public Health Laboratories National Center for Public Health Laboratory Leadership Cohort IV.
HOMELAND SECURITY and AMERICAN COUNCIL OF INDEPENDENT LABORATORIES An Environmental Sciences Section Perspective Robert Wyeth Severn Trent Laboratories.
African Business Leaders on Health GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 2010 Technical Assistance.
Laboratory Training for Field Epidemiologists Viral cultures Investigation strategies and methods May 2007.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Biosafety and the Southeast Asian Clinical Infectious Diseases Network (SEAICRN) Rogier van Doorn Clinical Microbiologist Wellcome Trust Major Overseas.
Prevention and improved treatment of communicable diseases (HIV/AIDS and TB), including increasing preparedness for bioterrorism and epidemics Anneli Taal,
National Institute of Health Pathom Sawanpanyalert, MD, DrPH National Institute of Health Department of Medical Sciences Ministry of Public Health, Thailand.
Laboratory Training for Field Epidemiologists Overview of Microbiology Methods Investigation strategies and methods May 2007.
Group Discussion Guyana, The Bahamas T & T, Jamaica Barbados, Haiti Suriname, Curacao.
National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control June 14, 2011 : The Food Safety Modernization Act: Implications.
Highlights of the PIHOA Regional Lab Initiative in the US-affiliated Pacific Islands Vasiti Uluiviti Regional Lab Coordinator PIHOA 58 th Meeting – Honolulu,
“History is a set of lies agreed upon.” Napoleon Bonaparte.
Biosafety/ Biosecurity in Georgia Lela Bakanidze, Ph.D. National Center for Disease Control and Medical Statistics of Georgia Scientific Networking and.
Global Foodborne Infections Network (GFN) Building capacity to detect, control and prevent foodborne and other enteric infections from farm to table National.
FIND Ongoing Activities What’s in the pipeline for Rapid DST? WHO Stop TB Department Supranational Reference Laboratory Network Meeting Paris, October.
Papua New Guinea Update 3 rd NIC Meeting 18 – 20 Beijing, China Berry Ropa National CSR Officer Department of Health Papua New Guinea.
USAFSAM IMMUNODIAGNOSTICS LABORATORY 25 March 2010 Presenters: SSgt Shoup, SSgt Eccleston Distribution Statement A: Approved for Public Release; distribution.
A Public Health Approach to Combating Bioterrorism Tarrant County Public Health Peggy Wittie, PhD Epidemiology Surveillance & Response Manager / Bioterrorism.
PHEP Capabilities John Erickson, Special Assistant Washington State Department of Health
David Featherstone EPI / IVB WHO/HQ Measles Partners Meeting September 2008 Washington Global Measles Rubella Laboratory Network: Update.
Laboratory Results and Operations in WHO Phase 6 Dr. Attaporn Taweetungtragoon CYBELES Phnom Penh, Cambodia October 12-15, 2009.
PIHOA’s Career Epidemiology Field Officer Supporting Epidemiology Preparedness in the Pacific Islands Thane Hancock MD MPH Field Services Branch.
Go to View > Master > Slide Master to edit Place, Month Year GLI and Global Fund focal point Feedback and updates Rachel Bauquerez.
Click to edit subtitle State Public Health Laboratory Bioterrorism Capacity Norman Crouch, PhD Director, Public Health Laboratory Minnesota Department.
“28,424 cases of Ebola and still counting—what have we learned
Dr Rochelle Adams ACC Project Manager On behalf of the ACC team AWACC November 2015 Health systems Strengthening for Success and Sustainability.
Early TB case detection in pre-trial detention centers (SIZOs) and prison colonies in Ukraine 46 th Union World Conference on Lung Health Cape Town, South.
Facility supervision by the District Health Teams (DHTs) in Rwanda Track1 Meeting Maputo, Mozambique, August 10 th -12 th Dr. Ruben Sahabo.
2015 Measles & Rubella Initiative Annual Partners Meeting, Human & Financial Costs of Measles and Rubella, 15 September 2015, Washington, DC Achieving.
BioPlex 2200 HIV Ag-Ab Assay
Presented by Senator the Honourable Jerry Narace Minister of Health Caribbean Public Health Agency (CARPHA) Ministry of Health.
SARS: International Coordination SARS: International Coordination and Collaboration James W. LeDuc, Ph.D. Director, Division of Viral and Rickettsial Diseases.
NEDSS Messaging Solution Division of Integrated Surveillance Systems and Services 09/26/2008 Arunkumar Srinivasan MS, NCPHI-CCHIS The findings and conclusions.
Title of the Change Project
laboratory management
Diagnostic Solution – MMPA Panel Discussion
PIHOA Regional Lab Coordinator PIHOA 60th Meeting - Honolulu, HI
Centre for Clinical Microbiology Meeting
California Clinical Laboratory Association
This is an archived document.
Walter Randolph Daley, DVM, MPH Chief, Field Services Branch
Molecular Diagnosis in Resource-Limited Settings Camilla Rodrigues, M
Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health
World Organisation for Animal Health
Deciphering TB Lab Reports
Workshop on the Revised WHO Guidance
Presentation transcript:

Department of Public Health and Social Services Guam Public Health Laboratory (GPHL) March 11, 2014

GPHL Updates: Completed Validation for Rubella and Rubeola IgM Cepheid GeneXpert PCR – set up, training and validation testing Cepheid GeneXpert Clinical Trials for Chlamydia and GC PCR – 1st quarter of 2012 Acquisition of New Applied Biosystems 7500 Real Time PCR System Set-up/install and train staff on new Applied Biosystems (AB) rt-PCR instrument BT Suite Renovation Completed

Update cont’d. Acquired and started use of Artel PCS pipette calibration instrument (2012) New tests on the Cepheid GeneXpert: Influenza PCR (A/B, 2009 H1N1) – Sept 2012, Chlamydia/GC PCR (urine, genital specimens) – Sept. 2013 Adopted the new CDC-recommended HIV testing algorithm (Biorad HIV Ag/Ab Combo, Biorad Multispot) – Nov. 2013 – capable of confirming HIV

Challenges: Funding to procure supplies, reagents and equipment to sustain current test menu Funding to procure supplies, reagents and equipment for future tests (e.g. water analysis, food testing) Training of staff in different updated processes in bacteriology Training of staff in influenza testing to improve and maintain competency

Plans for Building Capacity Level 2 Capacity building at GPHL 2014 – 2015: An SPC-PIHOA Collaboration Initiative: Provide training to skill-up microbiology lab diagnostic capacity Provide preparatory training for the enhancement of public health food and water microbiology lab capacity Provide technical assistance to strengthen lab-based surveillance of PPHSN outbreak-prone diseases Start validation of the following tests on the Cepheid GeneXpert: MTB/RIF, C. difficile PCR Awaiting CDC approval to acquire influenza and dengue RT-PCR reagent kits for AB 7500 PCR instrument for validation studies Start Validation for Water Analysis If AB 7500 RT-PCR instrument is capable of testing for bacterial agents in food-borne illnesses, start validation process

Plans for Building Capacity Cont’d. Renovate GPHL TB suite to conform with updated safety practices, to be followed by acquisition of instrument for MTB culture and sensitivity Department of Interior Funding approved for the renovation and purchase of a BACTEC MGIT 960 system Expand influenza panel testing to detect other subtypes Installation and training for the NEDSS (National Electronic Disease Surveillance System (NBS) for surveillance. Installation, set up, training for the Indian Health Services’ Resource patient Management System (RPMS) – laboratory information system with instrument interface and automated reporting.

Future Plans January 2014 – Governor of Guam informed that 13million dollars was approved for a new GPHL under the Department of Defense (OMNIBUS Appropriations Act of 2014) as part of the military buildup. Proposed Mission Statement: To provide diagnostic services to regionally important diseases and conditions that may impact the health of the community and region, and serve as a regional center of excellence for reference testing including evaluations of new diagnostic tools and training.

Projected Capabilities of New GPHL Upgraded from Biosafety (BSL) 1/2 to BSL 2/3 equipped to test clinical, environmental and radiological specimens Bacteriology and Virology Department: Basic bacterial cultures Confirmatory testing (i.e. salmonella, shigella, cholera) Susceptibility testing for different bacterial pathogens such as gonorrhea Testing for bacterial toxins from clinical and environmental samples and viral cultures

Cont’d. Serology/Immunology Department Molecular Diagnostic Department Dengue, leptospirosis, pertussis, measles, rubella and other infectious diseases. Screening for radioactive substances will be added to the test menu if instrumentation and training is provided. Molecular Diagnostic Department Expanded nucleic acid amplification test capabilities that will allow for influenza and dengue subtyping, and other pathogens in which non-culture tests are helpful in outbreak mitigation. Mycobacteriology Department Upgraded to perform not just acid-fact bacilli (AFB) smear microscopy but AFB culture, identification and drug susceptibility testing.

Sustainability Funding for staffing and laboratory operations is projected to be maintained through Government of Guam sources, HHS/CDC cooperative agreements, and current plans to develop a revolving fund through legislation to established a fee schedule for services. Partnerships with Department of Defense centers, including the Naval Health Research Center may be considered to provide additional support for sustainment.

Regional Plan The new GPHL will serve the DPHSS and also have the potential to provide confirmatory testing for numerous stakeholders and partners including other US Affiliated Pacific Island laboratories. Vision of GPHL is to serve as the regional hub for laboratory testing and training in Micronesia